Serveur d'exploration Tocilizumab - Checkpoint (PascalFrancis)

Index « AffRegInc.i » - entrée « Kobe »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Klinik I für Innere Medizin, Universitätsklinikum Köln < Kobe < Kobe Children's Hospital  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000018 (2014) Shumpei Yokota [Japon] ; Tomoyuki Imagawa ; Masaaki Mori ; Takako Miyamae ; Syuji Takei ; Naomi Iwata ; Hiroaki Umebayashi ; Takuji Murata ; Mari Miyoshi ; Minako Tomiita ; Norihiro Nishimoto ; Tadamitsu KishimotoLongterm Safety and Effectiveness of the Anti-interleukin 6 Receptor Monoclonal Antibody Tocilizumab in Patients with Systemic Juvenile Idiopathic Arthritis in Japan
000098 (2012) Shigeyuki Ebara [Japon] ; Soken-Nakazawa J. Song [Japon] ; Hiroyuki Mizuta [Japon] ; Yasushi Ito [Japon] ; Kenji Hasegawa [Japon] ; Tsuneko Kamata [Japon] ; Teppei Matsumura-Nishikawa [Japon] ; Takafumi Ogawa [Japon] ; Jyunichi Soneda [Japon] ; Kazuyuki Yoshizaki [Japon]Interleukin-6-producing dermoid cyst associated with multicentric Castleman's disease
000110 (2012) Ryoko Sakai [Japon] ; Michi Tanaka [Japon] ; Toshihiro Nanki [Japon] ; Kaori Watanabe [Japon] ; Hayato Yamazaki [Japon] ; Ryuji Koike [Japon] ; Hayato Nagasawa [Japon] ; Koichi Amano [Japon] ; Kazuyoshi Saito [Japon] ; Yoshiya Tanaka [Japon] ; Satoshi Ito [Japon] ; Takayuki Sumida [Japon] ; Atsushi Ihata [Japon] ; Yoshiaki Ishigatsubo [Japon] ; Tatsuya Atsumi [Japon] ; Takao Kolke [Japon] ; Atsuo Nakajima [Japon] ; Naoto Tamura [Japon] ; Takao Fujii [Japon] ; Hiroaki Dobashi [Japon] ; Shigeto Tohma [Japon] ; Takahiko Sugihara [Japon] ; Yukitaka Ueki [Japon] ; Akira Hashiramoto [Japon] ; Atsushi Kawakami [Japon] ; Noboru Hagino [Japon] ; Nobuyuki Miyasaka [Japon] ; Masayoshi Harigai [Japon]Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules
000202 (2010) Yasuharu Sato [Japon] ; Masaru Kojima [Japon] ; Katsuyoshi Takata [Japon] ; Toshiaki Morito [Japon] ; Kohichi Mizobuchi [Japon] ; Takehiro Tanaka [Japon] ; Dai Inoue [Japon] ; Hideyuki Shiomi [Japon] ; Haruka Iwao [Japon] ; Tadashi Yoshino [Japon]Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/AffRegInc.i -k "Kobe" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/AffRegInc.i  \
                -Sk "Kobe" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    AffRegInc.i
   |clé=    Kobe
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021